prostate cancer

A tumor without a back-up: New molecular marker may improve prostate cancer treatment

Making drug resistance a weak point in metastatic prostate cancer

A new computational tool, SpotNeoMet, developed at the Weizmann Institute, detects resistance mutations that recur in many patients and create neoantigens – a possible target for “precision” immunotherapy for broad patient groups

A new drug for imaging cancer in soft tissues and detecting it in early stages

Today there are over 22,000 men living in Israel who have ever had prostate cancer * a collection of studies

like a kaleidoscope

The fungus that fights cancer

Tools combined in engineering, medicine and as a metaphor for integration between fields of knowledge

An innovative method for drug delivery - nano-jets

Take the prostate out of the fire - as early as possible

Is prostate cancer caused by a virus?

Artificial lighting increases the incidence of prostate cancer

6 new prostate cancer patients are diagnosed in Israel every day

A researcher at the Hebrew University has developed a method to treat prostate cancer, clinical trials are expected in about two years

Weizmann Institute scientists have developed a new approach to detect cancer metastases and destroy them

Sweet, low-calorie, healthy and tasty - yacon for the diabetic menu

We may finally have found a use for the spleen: aiding in the production of insulin